Results 101 to 110 of about 866,587 (181)

Predictors of immunological failure after initial response to highly active antiretroviral therapy in HIV-1-infected adults: A EuroSIDA study [PDF]

open access: yes, 2004
BACKGROUND: Factors that determine the immunological response to highly active antiretroviral therapy (HAART) are poorly defined. OBJECTIVE: Our aim was to investigate predictors of immunological failure after initial CD4(+) response.
Horban, A   +19 more
core  

WHO Clinical Staging of HIV Infection and Disease, Tuberculosis and Eligibility for Antiretroviral Treatment: Relationship to CD4 Lymphocyte Counts. [PDF]

open access: yes, 2005
SETTING: Thyolo district, Malawi. OBJECTIVES: To determine in HIV-positive individuals aged over 13 years CD4 lymphocyte counts in patients classified as WHO Clinical Stage III and IV and patients with active and previous tuberculosis (TB). DESIGN: Cross-
Pasulani, O   +13 more
core  

Improvement of the predictive value of CD4+ lymphocyte count by b2-microglobulin, immunoglobulin A and erythrocyte sedimentation rate [PDF]

open access: yes, 1993
Schwartländer, Bernhard   +6 more
core   +1 more source

Etiological and immunological aspects of equine hoof canker. [PDF]

open access: yesVet Res Commun
Styková E   +5 more
europepmc   +1 more source

Dear Colleague Letter from Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, to HIV Surveillance Coordinators, AIDS Directors, State Epidemiologisits, State Health Officers, and State Public Health Lab Directors about laboratory reporting of HIV-related tests, incluidng all CD4+ T-lymphoyte (CD4) results and all viral load test results

open access: yes
Measuring progress towards goals of the National HIV/AIDS Strategy (NHAS) relies on laboratory reporting of HIV-related tests to the local and national HIV surveillance systems. The Centers for Disease Control and Prevention (CDC) recommends reporting of

core  

Home - About - Disclaimer - Privacy